Clinical effect evaluation of pilocarpine in the treatment of presbyopia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200059049

Enrollment

Unknown

Registered

2022-04-23

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with presbyopia in our hospital were selected. The subjects (40-55 years old) were in good general health with objective and subjective evidence of presbyopia. Bilaterally, high contrast corrected visual acuity was 0.8 or better, and medium and high contrast corrected near visual acuity (measured at 40 cm) was 0.5.

Exclusion criteria

Exclusion criteria: 1. Underwent refractive surgery, artificial eye, clinically relevant dry eye, glaucoma, or any type of retinal problem that might affect the results of this study, and allergy to the component of cariorutin eye drops.

Design outcomes

Primary

Measure	Time frame
Near vision;Paracentral vision;Distant vision;Visual analysis;Anterior chamber depth, ACD;	—

Countries

China

Contacts

Public ContactTing Wang

Shandong Eye Hospital

wt-ting@163.com+86 13869182795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026